University of Sydney

#Alzheimer's #Bacteria #Brain cancer #Cancer immunotherapy #Clinical trial #Drug resistance #Fast Track designation #FDA #Gene therapy #Life sciences #Melanoma #Siren Biotechnology #UK government #University of Sydney

DDW Highlights: 10 February 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, innovative therapies showed the way to more effective cancer treatments. Elsewhere, how can… Read More

#Podcasts

#Alzheimer's #Bacteria #Brain cancer #Cancer immunotherapy #Clinical trial #Drug resistance #Fast Track designation #FDA #Gene therapy #Life sciences #Melanoma #Siren Biotechnology #UK #UK government #University of Sydney

This week in Drug Discovery (2 – 6 February) 

News round-up for 2 – 6 February by Bruno Quinney, Content Team at DDW.  This week in DDW, innovative therapies could pave the way to more effective cancer treatments. Elsewhere, how can brain function be improved in Alzheimer’s patients?  The top stories:      Immunotherapy before surgery… Read More

#News

#Bacteria #Drug resistance #University of Sydney

Sugar-targeting antibody could kill drug-resistant bacteria

Sugar molecules found on bacterial cells could offer a target to killing drug-resistant bacteria, scientists suggest.  Researchers have designed antibodies that recognise the sugar found only on bacterial cells, which could underpin a new generation of immunotherapies for multidrug resistant hospital-acquired infections.  The findings, published in … Read More

#News

Doctor points at child's brain scan
#Australia #Brain cancer #Checkpoint inhibitor therapies #Immunotherapy #Oncology #University of Sydney

Study shows potential for triple immunotherapy in glioblastoma

An experimental cancer treatment developed by researchers at the Melanoma Institute Australia paves the way for a clinical trial to be conducted by researchers at the Brain Cancer Centre in Melbourne.  It is the first documented use of neoadjuvant triple immunotherapy in glioblastoma, involving a combination of… Read More

#Cancer Research #News #Trending News

RNA
#CRISPR #Gene editing #Genetics / genomics #Interview #RNA #University of Sydney

Beyond CRISPR – what a new tool offers gene editing

DDW Editor Reece Armstrong speaks to Dr Sandro Ataide, Senior Lecturer in Structural Biology at the School of Life and Environmental Sciences Sydney Drug Discovery Initiative (DDI). Earlier this year, Dr Ataide’s team developed a gene-editing tool called SeekRNA that uses a programmable ribonucleic acid (RNA) strand that can directly… Read More

#Exclusive Content

Cobra
#Drug repurposing #Liverpool School of Tropical Medicine #LMICs #University of Sydney #World Health Organization

Heparin provides a cheap antidote for cobra bites

Scientists at the University of Sydney and Liverpool School of Tropical Medicine have revealed that a commonly used blood thinner, heparin, can be repurposed as an inexpensive antidote for cobra venom. Cobras kill thousands of people a year worldwide and many more are seriously maimed by… Read More

#News

Research-lead-Dr-Sandro-Ataide-left-and-first-author-Rezwan-Siddiquee-with-Caitlin-McCormack-right
#CRISPR #Gene editing #Genetic engineering #University of Sydney

New gene-editing tool is more accurate than CRISPR

Scientists at the University of Sydney have developed a gene editing tool with greater accuracy and flexibility than CRISPR. SeekRNA uses a programmable ribonucleic acid (RNA) strand that can directly identify sites for insertion in genetic sequences, simplifying the editing process and reducing errors. Read More

#Editor's Choice #News